Takayama, T <br/><br/>
Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.  [electronic resource] 

 -  British journal of cancer  Oct 2007 
 - 851-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6603957  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Docetaxel<br/>Drug Combinations<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Intestinal Neoplasms--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Oxonic Acid--administration & dosage<br/>Stomach Neoplasms--drug therapy<br/>Taxoids--administration & dosage<br/>Tegafur--administration & dosage<br/>Vascular Endothelial Growth Factor A--metabolism